STUDY SEARCH RESULTS

1 study found for your search request:  V116-003

Safety and immunogenicity of V116 in pneumococcal vaccine-naïve adults (V116-003, STRIDE-3)
Condition: Pneumococcal infection
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT05425732
Status: Completed
Has Results




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site